Report overview
A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
This report aims to provide a comprehensive presentation of the global market for Pressurized Metered Dose Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pressurized Metered Dose Inhaler. This report contains market size and forecasts of Pressurized Metered Dose Inhaler in global, including the following market information:
Global Pressurized Metered Dose Inhaler Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pressurized Metered Dose Inhaler Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Pressurized Metered Dose Inhaler companies in 2022 (%)
The global Pressurized Metered Dose Inhaler market was valued at US$ 6205.4 million in 2022 and is projected to reach US$ 7815 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
We surveyed the Pressurized Metered Dose Inhaler manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pressurized Metered Dose Inhaler Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Pressurized Metered Dose Inhaler Market Segment Percentages, by Type, 2022 (%)
Manual Pressurized Metered Dose Inhaler
Smart Pressurized Metered Dose Inhaler
Global Pressurized Metered Dose Inhaler Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Pressurized Metered Dose Inhaler Market Segment Percentages, by Application, 2022 (%)
Asthma
COPD
Others
Global Pressurized Metered Dose Inhaler Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Pressurized Metered Dose Inhaler Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pressurized Metered Dose Inhaler revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pressurized Metered Dose Inhaler revenues share in global market, 2022 (%)
Key companies Pressurized Metered Dose Inhaler sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Pressurized Metered Dose Inhaler sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Chiesi Farmaceutici S.p.A
AstraZeneca
Teva
Merck & Co. Inc
Boehringer Ingelheim
Mylan
Arkon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pressurized Metered Dose Inhaler, market overview.
Chapter 2: Global Pressurized Metered Dose Inhaler market size in revenue and volume.
Chapter 3: Detailed analysis of Pressurized Metered Dose Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pressurized Metered Dose Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pressurized Metered Dose Inhaler capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
